Hypoxia characterizes the tumor microenvironment and is associated with modulating angiogenesis, vasculogenesis, and cancer progression by triggering factor production in stromal cells like VEGF or lysyl oxidase (LOX) [65]. The gene discussed is LOX; the disease is neoplasm.